Apolipoprotein C2 Deficiency Latest Advances
Find the Latest Research About Apolipoprotein C2 Deficiency
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 839 publications
Plozasiran (Redemplo) for familial chylomicronemia syndrome.
Journal: The Medical letter on drugs and therapeutics
Published: April 10, 2026
The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides.
Journal: Nucleic acid therapeutics
Published: March 25, 2026
The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome.
Journal: Expert review of endocrinology & metabolism
Published: March 20, 2026
2025 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 12, 2026
Neonatal severe hypertriglyceridaemia: A novel lipoprotein lipase gene splicing variant.
Journal: BMJ case reports
Published: December 21, 2025
2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?
Journal: Archives of medical science : AMS
Published: December 12, 2025
Familial Chylomicronemia Syndrome-Lipemia Retinalis.
Journal: Ophthalmology. Retina
Published: December 10, 2025
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemia.
Journal: Journal of clinical lipidology
Published: December 08, 2025
Last Updated: 04/28/2026